Transplantation of electively aborted human fetal tissue: physicians' attitudes

M A Mullen1, J I Williams, F H Lowy

  • 1Centre for Bioethics, University of Toronto, Ont.

Abstract

Insights

Most Ontario physicians support using fetal tissue for transplantation (FTT). Key ethical considerations include separating abortion and donation decisions and ensuring tissue demand doesn't impede abortion access.

Area of Science:

  • Medical Ethics
  • Transplantation Medicine
  • Public Health Policy

Background:

  • Electively aborted fetal tissue transplantation (FTT) presents complex ethical and logistical challenges.
  • Understanding healthcare provider attitudes is crucial for developing effective public policy.

Purpose of the Study:

  • To gather empirical data on the perspectives of Ontario family physicians and gynecologists regarding FTT.
  • To inform Canadian public policy on the ethical implementation of FTT.

Main Methods:

  • A cross-sectional survey was conducted among random samples of Ontario family physicians and gynecologists.
  • Response rate was 72% (248 family physicians, 186 gynecologists).
  • Attitudes toward incentives, patient management, consent, and supply/demand were assessed.

Main Results:

  • 75% opposed incentives for fetal tissue collection during abortion.
  • 90% believed abortion and donation decisions must be separate.
  • 94% agreed donation should only be discussed post-abortion decision.
  • 88% stated FTT demand should not affect abortion technology access.

Conclusions:

  • General approval for FTT exists among surveyed physicians.
  • Discrepancies between global and practice-oriented responses highlight policy development needs.
  • Effective Canadian public policy requires careful consideration of these physician attitudes.

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...